Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 32% ± 8% | |
lung | 10 studies | 40% ± 21% | |
peripheral blood | 9 studies | 23% ± 13% | |
intestine | 8 studies | 44% ± 21% | |
eye | 7 studies | 24% ± 9% | |
kidney | 4 studies | 35% ± 21% | |
bone marrow | 4 studies | 24% ± 9% | |
uterus | 4 studies | 40% ± 16% | |
breast | 4 studies | 45% ± 11% | |
liver | 4 studies | 20% ± 4% | |
lymph node | 4 studies | 43% ± 21% | |
prostate | 3 studies | 29% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 17223.91 | 2641 / 2642 | 100% | 1382.62 | 704 / 705 |
ovary | 100% | 26837.05 | 180 / 180 | 100% | 829.79 | 428 / 430 |
thymus | 100% | 8467.23 | 652 / 653 | 97% | 710.08 | 587 / 605 |
prostate | 96% | 4863.62 | 236 / 245 | 100% | 1058.05 | 500 / 502 |
breast | 91% | 4608.01 | 419 / 459 | 99% | 905.04 | 1104 / 1118 |
uterus | 95% | 4875.49 | 162 / 170 | 89% | 585.09 | 409 / 459 |
lung | 88% | 2910.88 | 508 / 578 | 91% | 434.20 | 1056 / 1155 |
stomach | 81% | 3765.81 | 289 / 359 | 99% | 668.19 | 282 / 286 |
intestine | 61% | 3359.37 | 591 / 966 | 99% | 725.25 | 523 / 527 |
bladder | 67% | 2096.24 | 14 / 21 | 92% | 595.59 | 465 / 504 |
skin | 50% | 1265.54 | 910 / 1809 | 97% | 947.43 | 459 / 472 |
adrenal gland | 100% | 4288.28 | 258 / 258 | 28% | 91.49 | 65 / 230 |
kidney | 76% | 2097.80 | 68 / 89 | 45% | 107.38 | 401 / 901 |
pancreas | 24% | 506.55 | 78 / 328 | 95% | 565.78 | 169 / 178 |
esophagus | 20% | 460.98 | 293 / 1445 | 84% | 386.61 | 154 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 427.16 | 1 / 1 |
spleen | 100% | 4857.41 | 240 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 785.27 | 27 / 29 |
tonsil | 0% | 0 | 0 / 0 | 87% | 299.76 | 39 / 45 |
adipose | 85% | 3123.98 | 1020 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 74% | 234.74 | 59 / 80 |
liver | 38% | 900.61 | 85 / 226 | 35% | 117.23 | 143 / 406 |
heart | 57% | 1839.97 | 490 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 52% | 4781.24 | 485 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 22% | 715.47 | 296 / 1335 | 0% | 0 | 0 / 0 |
muscle | 1% | 25.07 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007015 | Biological process | actin filament organization |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0008283 | Biological process | cell population proliferation |
GO_0007417 | Biological process | central nervous system development |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005516 | Molecular function | calmodulin binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MARCKSL1 |
Protein name | MARCKS-related protein (MARCKS-like protein 1) (Macrophage myristoylated alanine-rich C kinase substrate) (Mac-MARCKS) (MacMARCKS) |
Synonyms | MLP MRP |
Description | FUNCTION: Controls cell movement by regulating actin cytoskeleton homeostasis and filopodium and lamellipodium formation . When unphosphorylated, induces cell migration (By similarity). When phosphorylated by MAPK8, induces actin bundles formation and stabilization, thereby reducing actin plasticity, hence restricting cell movement, including neuronal migration (By similarity). May be involved in coupling the protein kinase C and calmodulin signal transduction systems (By similarity). . |
Accessions | ENST00000329421.8 P49006 |